Berkshire Hathaway Takes New Stakes in UnitedHealth and Nucor, Sells Apple Shares
PorAinvest
viernes, 15 de agosto de 2025, 7:13 am ET1 min de lectura
AAPL--
The Omaha-based conglomerate acquired a new stake in UnitedHealth during the second quarter of 2025, with the exact size of the stake not disclosed. The move comes as UnitedHealth faces a Justice Department investigation into its Medicare billing practices and a public backlash against rising healthcare costs. Despite these challenges, the insurer's stock saw a significant boost after the disclosure, indicating investor confidence in the company's future prospects.
Berkshire Hathaway also took a new stake in Nucor, the steel manufacturer, acquiring 6.61 million shares valued at $856.8 million. This investment is part of Berkshire's ongoing strategy to diversify its portfolio and invest in sectors that offer long-term growth potential.
Meanwhile, Berkshire Hathaway reduced its position in Apple by approximately 7%. The exact details of the reduction were not disclosed, but it is clear that the conglomerate is adjusting its portfolio to reflect changing market conditions and investment opportunities.
These moves come as Berkshire Hathaway prepares for a leadership transition. Warren Buffett, who will turn 95 this month, is stepping down as CEO at the end of the year, with Greg Abel taking over. Buffett will remain as chairman of the board.
References:
[1] https://www.cnbc.com/2025/08/14/warren-buffetts-berkshire-hathaway-unh.html
[2] https://seekingalpha.com/news/4485669-berkshire-hathaway-takes-new-stakes-in-unitedhealth-nucor-pares-back-on-apple
NUE--
UNH--
Berkshire Hathaway, led by Warren Buffett, has taken new stakes in UnitedHealth and Nucor, while reducing its position in Apple. UnitedHealth stock rose 8.2% in after-hours trading following the disclosure of Berkshire Hathaway's new stake in the health insurer. The exact size of the stake was not disclosed.
Berkshire Hathaway, led by Warren Buffett, has taken new stakes in UnitedHealth and Nucor, while reducing its position in Apple. UnitedHealth stock rose 8.2% in after-hours trading following the disclosure of Berkshire Hathaway's new stake in the health insurer.The Omaha-based conglomerate acquired a new stake in UnitedHealth during the second quarter of 2025, with the exact size of the stake not disclosed. The move comes as UnitedHealth faces a Justice Department investigation into its Medicare billing practices and a public backlash against rising healthcare costs. Despite these challenges, the insurer's stock saw a significant boost after the disclosure, indicating investor confidence in the company's future prospects.
Berkshire Hathaway also took a new stake in Nucor, the steel manufacturer, acquiring 6.61 million shares valued at $856.8 million. This investment is part of Berkshire's ongoing strategy to diversify its portfolio and invest in sectors that offer long-term growth potential.
Meanwhile, Berkshire Hathaway reduced its position in Apple by approximately 7%. The exact details of the reduction were not disclosed, but it is clear that the conglomerate is adjusting its portfolio to reflect changing market conditions and investment opportunities.
These moves come as Berkshire Hathaway prepares for a leadership transition. Warren Buffett, who will turn 95 this month, is stepping down as CEO at the end of the year, with Greg Abel taking over. Buffett will remain as chairman of the board.
References:
[1] https://www.cnbc.com/2025/08/14/warren-buffetts-berkshire-hathaway-unh.html
[2] https://seekingalpha.com/news/4485669-berkshire-hathaway-takes-new-stakes-in-unitedhealth-nucor-pares-back-on-apple

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios